IDIOTYPIC VACCINATION AGAINST B CELL LYMPHOMA

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20030072751A1
SERIAL NO

07493511

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides a method of inducing an effective immune response to pathogenic lymphocytes by administering dendritic cells previously pulsed with the idiotype protein of interest. In one embodiment, a method for the active immunization of a mammal against lymphoma is provided. This embodiment comprises exposing dendritic cells to idiotype Ig to make idiotype pulsed dendritic cells and injecting the idiotype pulsed dendritic cells back into the mammal, whereby immunity against lymphoma cells is induced. In another embodiment, the invention relates to the administration of both idiotypic cells and pulsed dendritic cells.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IMMUNE RESPONSE CORPORATION THE5935 DARWIN COURT CARLSBAD CALIFORNIA 92008 UNITED STATES OF AMERICA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BOHLEN, HERIBERT BRUSSELS, BE 19 109
THIELEMANS, KRISTIAAN BRUSSELS, BE 5 15
URBAIN, JACQUES LASNE, BE 6 6
VAN, CAMP BENJAMIN BRUSSELS, BE 25 462

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation